HPS Pharmacies wish to give notice that Pfizer Australia are currently experiencing an interruption to the supply of:
Tranexamic acid 500mg
Normal supplies are expected to resume on 31 January, 2017. While wholesaler stocks are exhausted, HPS Pharmacies’ Compounding department, HPS Compounding, is able to manufacture and supply tranexamic acid 500mg in capsule form upon receipt of a valid prescription. The compounded product will be manufactured in accordance with the complex compounding guidelines for individual patients, and has a shelf-life of six month from the date of manufacture. The capsules will be compounded in packs of 100.
To place an order, please send a valid prescription to HPS Compounding at email@example.com or via fax on 08 8375 3570.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact HPS Compounding on 08 8193 9110.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.